Topiramate exposure in pregnancy: PRAC recommends new measures
The European Medicines Agency (EMA) is recommending new measures to prevent children’s exposure to topiramate-containing medicines during pregnancy due to an increased risk of neurodevelopmental problems. Topiramate, used for epilepsy and migraine treatment, has known birth defect risks when used during pregnancy. The recommendations include: The product information for topiramate-containing medicines will be updated to […]
Topiramate exposure in pregnancy: PRAC recommends new measures Read More »